Suppr超能文献

中间型遗传性运动感觉神经病

Intermediate Charcot-Marie-Tooth disease.

作者信息

Liu Lei, Zhang Ruxu

机构信息

Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, 410013, China.

出版信息

Neurosci Bull. 2014 Dec;30(6):999-1009. doi: 10.1007/s12264-014-1475-7. Epub 2014 Oct 17.

Abstract

Charcot-Marie-Tooth (CMT) disease is a common neurogenetic disorder and its heterogeneity is a challenge for genetic diagnostics. The genetic diagnostic procedures for a CMT patient can be explored according to the electrophysiological criteria: very slow motor nerve conduction velocity (MNCV) (<15 m/s), slow MNCV (15-25 m/s), intermediate MNCV (25-45 m/s), and normal MNCV (>45 m/s). Based on the inheritance pattern, intermediate CMT can be divided into dominant (DI-CMT) and recessive types (RI-CMT). GJB1 is currently considered to be associated with X-linked DI-CMT, and MPZ, INF2, DNM2, YARS, GNB4, NEFL, and MFN2 are associated with autosomal DI-CMT. Moreover, GDAP1, KARS, and PLEKHG5 are associated with RI-CMT. Identification of these genes is not only important for patients and families but also provides new information about pathogenesis. It is hoped that this review will lead to a better understanding of intermediate CMT and provide a detailed diagnostic procedure for intermediate CMT.

摘要

夏科-马里-图斯(CMT)病是一种常见的神经遗传性疾病,其异质性对基因诊断构成挑战。可根据电生理标准探索CMT患者的基因诊断程序:运动神经传导速度(MNCV)极慢(<15米/秒)、MNCV慢(15 - 25米/秒)、MNCV中等(25 - 45米/秒)和MNCV正常(>45米/秒)。根据遗传模式,中间型CMT可分为显性(DI-CMT)和隐性类型(RI-CMT)。目前认为GJB1与X连锁显性CMT相关,而MPZ、INF2、DNM2、YARS、GNB4、NEFL和MFN2与常染色体显性CMT相关。此外,GDAP1、KARS和PLEKHG5与隐性CMT相关。这些基因的鉴定不仅对患者及其家庭很重要,还为发病机制提供了新信息。希望本综述能增进对中间型CMT的理解,并为中间型CMT提供详细的诊断程序。

相似文献

1
Intermediate Charcot-Marie-Tooth disease.
Neurosci Bull. 2014 Dec;30(6):999-1009. doi: 10.1007/s12264-014-1475-7. Epub 2014 Oct 17.
2
Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
J Neurol. 2017 Aug;264(8):1655-1677. doi: 10.1007/s00415-017-8474-3. Epub 2017 Mar 31.
3
Genetic epidemiology of Charcot-Marie-Tooth disease.
Acta Neurol Scand Suppl. 2012(193):iv-22. doi: 10.1111/ane.12013.
5
[Guidelines for molecular diagnosis of Charcot-Marie-Tooth disease].
Neurologia. 2012 Apr;27(3):169-78. doi: 10.1016/j.nrl.2011.04.015. Epub 2011 Jun 23.
6
Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.
Neuromolecular Med. 2006;8(1-2):123-30. doi: 10.1385/nmm:8:1-2:123.
7
Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population.
Neuromuscul Disord. 2013 Aug;23(8):647-51. doi: 10.1016/j.nmd.2013.05.005. Epub 2013 Jun 3.
9
Clinical and genetic spectra of Charcot-Marie-Tooth disease in Chinese Han patients.
J Peripher Nerv Syst. 2017 Mar;22(1):13-18. doi: 10.1111/jns.12195.
10
Diagnostic yield of targeted sequential and massive panel approaches for inherited neuropathies.
Clin Genet. 2020 Aug;98(2):185-190. doi: 10.1111/cge.13793. Epub 2020 Jun 29.

引用本文的文献

1
Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease.
Brain. 2024 Sep 3;147(9):3144-3156. doi: 10.1093/brain/awae064.
3
Novel PLEKHG5 mutations in a patient with childhood-onset lower motor neuron disease.
Ann Clin Transl Neurol. 2021 Jan;8(1):294-299. doi: 10.1002/acn3.51265. Epub 2020 Dec 4.
4
The formin INF2 in disease: progress from 10 years of research.
Cell Mol Life Sci. 2020 Nov;77(22):4581-4600. doi: 10.1007/s00018-020-03550-7. Epub 2020 May 25.
6
Inverted formins: A subfamily of atypical formins.
Cytoskeleton (Hoboken). 2017 Nov;74(11):405-419. doi: 10.1002/cm.21409. Epub 2017 Sep 29.
7
Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
J Neurol. 2017 Aug;264(8):1655-1677. doi: 10.1007/s00415-017-8474-3. Epub 2017 Mar 31.
8
Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.
Cochrane Database Syst Rev. 2015 Dec 11;2015(12):CD011952. doi: 10.1002/14651858.CD011952.
10
NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.
J Neurol. 2015 May;262(5):1289-300. doi: 10.1007/s00415-015-7709-4. Epub 2015 Apr 1.

本文引用的文献

3
Neuropathologic characterization of INF2-related Charcot-Marie-Tooth disease: evidence for a Schwann cell actinopathy.
J Neuropathol Exp Neurol. 2014 Mar;73(3):223-33. doi: 10.1097/NEN.0000000000000047.
4
Two novel MPZ mutations in Chinese CMT patients.
J Peripher Nerv Syst. 2013 Sep;18(3):256-60. doi: 10.1111/jns5.12040.
6
PLEKHG5 deficiency leads to an intermediate form of autosomal-recessive Charcot-Marie-Tooth disease.
Hum Mol Genet. 2013 Oct 15;22(20):4224-32. doi: 10.1093/hmg/ddt274. Epub 2013 Jun 17.
7
A review of genetic counseling for Charcot Marie Tooth disease (CMT).
J Genet Couns. 2013 Aug;22(4):422-36. doi: 10.1007/s10897-013-9584-4. Epub 2013 Apr 21.
8
Exome sequencing identifies GNB4 mutations as a cause of dominant intermediate Charcot-Marie-Tooth disease.
Am J Hum Genet. 2013 Mar 7;92(3):422-30. doi: 10.1016/j.ajhg.2013.01.014. Epub 2013 Feb 21.
9
[Classification and molecular diagnostic procedure for Chacort-Marie-Tooth disease].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Oct;29(5):553-7. doi: 10.3760/cma.j.issn.1003-9406.2012.05.011.
10
Novel INF2 mutation p. L77P in a family with glomerulopathy and Charcot-Marie-Tooth neuropathy.
Pediatr Nephrol. 2013 Feb;28(2):339-43. doi: 10.1007/s00467-012-2299-1. Epub 2012 Sep 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验